MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
GELS Gelteq
- 2.590
- -0.130-4.78%
Close Dec 20 16:00 ET
- 2.590
- 0.0000.00%
Post 20:01 ET
24.44MMarket Cap-11.02P/E (TTM)
2.930High2.420Low82.70KVolume2.730Open2.720Pre Close215.38KTurnover2.71%Turnover RatioLossP/E (Static)9.44MShares5.50052wk High2.59P/B7.90MFloat Cap1.42052wk Low--Dividend TTM3.05MShs Float5.500Historical High--Div YieldTTM18.75%Amplitude1.420Historical Low2.604Avg Price1Lot Size
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Gelteq Stock Forum
Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug
Tuesday, 17th December at 8:30 am
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) ("Gelteq" or the "Company"), a clinical and biotechnology company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, sports, and other products, announces today that the U.S. Food and Drug Administration ("FDA")...
Gelteq Receives FDA Approval of Its Suitability Petition for New Animal Drug
ayo
$CleanCore Solutions (ZONE.US)$ 5 dollars
$Gaxos.ai (GXAI.US)$ 8 dollars
lmk if any if these are long shots or risky and why and ill remove before market opens
No comment yet